Back to Trades
Total Value
$1.0M
Net $580.5K sold
Filing Date
Jun 25, 2026
1 transaction
Sales
$580.5K
1 transaction
Trade Summary
On Jun 25, 2026, Ring Christine, Chief Legal Officer, sold $1.0M of Nurix Therapeutics, Inc. (NRIX) across 1 transaction. The filing covers Common Stock and reflects net selling of $580.5K. Reported prices ranged from $7.26 to $20.06. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Nurix Therapeutics, Inc.
- Ticker Symbol
- NRIX
- CIK
- 0001549595
Insider Information
- Name
- Ring Christine
- Role
- Chief Legal Officer
- Location
- BRISBANE, CA
Filing Details
- Filing Date
- Jun 25, 2026
- Transaction Date
- Jun 25, 2026
- Accession Number
- 0001817199-26-000022
- Form Type
- 4
- Net Trading Amount
- -$580.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | 13,333 | $7.26 | Exercise | $96.8K |
| Jun 25, 2026 | Common Stock | 15,602 | $8.72 | Exercise | $136.0K |
| Jun 25, 2026 | Common Stock | 28,935 | $20.06 | Sale | $580.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | NRIX derivative | 13,333 | $7.26 | Exercise | $96.8K |
| Jun 25, 2026 | NRIX derivative | 15,602 | $8.72 | Exercise | $136.0K |
Want live alerts when Ring Christine trades again?
Download Insider Trades to track NRIX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- (F2)Represents the weighted average sale price. The lowest price at which shares were sold was $20.00 and the highest price at which shares were sold was $20.40. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- (F3)The stock option vested as to 1/48 of the total shares monthly beginning February 18, 2020, until the option was fully vested on January 18, 2024.
- (F4)The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027.